Advanced search
Publication Cover
Gynecological Endocrinology Volume 37, 2021 - Issue 10
Submit an article Journal homepage
227
Views
3
CrossRef citations to date
0
Altmetric
OVARIAN FAILURE

The protective effects of resveratrol pretreatment in cyclophosphamide-induced rat ovarian injury: an vivo study

Zhaoyan Niea Department of Histology and Embryology, Hebei Medical University, Shijiazhuang, PR China;b Department of Reproductive Medicine, Fourth Hospital of Hebei Medical University, Shijiazhuang, PR ChinaORCID Iconhttps://orcid.org/0000-0001-9237-1009View further author information
ORCID Icon,
Lei Zhanga Department of Histology and Embryology, Hebei Medical University, Shijiazhuang, PR ChinaCorrespondence[email protected]
View further author information
,
Wei Chena Department of Histology and Embryology, Hebei Medical University, Shijiazhuang, PR ChinaView further author information
,
Yanan Zhanga Department of Histology and Embryology, Hebei Medical University, Shijiazhuang, PR ChinaView further author information
,
Wei Wanga Department of Histology and Embryology, Hebei Medical University, Shijiazhuang, PR ChinaView further author information
,
Rui Huaa Department of Histology and Embryology, Hebei Medical University, Shijiazhuang, PR ChinaView further author information
,
Tiantian Zhanga Department of Histology and Embryology, Hebei Medical University, Shijiazhuang, PR ChinaView further author information
,
Chunfang Zhaoa Department of Histology and Embryology, Hebei Medical University, Shijiazhuang, PR ChinaView further author information
,
Miao Gonga Department of Histology and Embryology, Hebei Medical University, Shijiazhuang, PR ChinaView further author information
&
Haifeng Wuc Department of Medical Laboratory, Hebei Chest Hospital, Shijiazhuang, PR ChinaView further author information
 show all
Pages 914-919 | Received 15 Dec 2020, Accepted 01 Feb 2021, Published online: 17 Feb 2021

References

  • Salih SM, Elsarrag SZ, Prange E, et al. Evidence to incorporate inclusive reproductive health measures in guidelines for childhood and adolescent cancer survivors. J Pediatr Adolescent Gynecol. 2015;28(2):95–101.
  • Wallace WHB, Thomson AB, Saran F, et al. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62(3):738–744.
  • Selter J, Huang Y, Becht L, et al. Use of fertility preservation services in female reproductive-aged cancer patients. Am J Obstet Gynecol . 2019;221(4):328.e1–328.e16.
  • Ben-Aharon I, Shalgi R. What lies behind chemotherapy-induced ovarian toxicity? Reproduction. 2012;144(2):153–163.
  • Tilly JL. Commuting the death sentence: how oocytes strive to survive. Nat Rev Mol Cell Biol. 2001;2(11):838–848.
  • Comish PB, Drumond AL, Kinnell HL, et al. Fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice. PLoS One. 2014;9(4):e93311.
  • Petrillo SK, Desmeules P, Truong TQ, et al. Detection of DNA damage in oocytes of small ovarian follicles following phosphoramide mustard exposures of cultured rodent ovaries in vitro. Toxicol Appl Pharmacol. 2011;253(2):94–102.
  • Kalich-Philosoph L, Roness H, Carmely A, et al. Cyclophosphamide triggers follicle activation and “burnout”; AS101 prevents follicle loss and preserves fertility. Sci Transl Med. 2013; 5:185–ra162.
  • Oh WY, Shahidi F. Antioxidant activity of resveratrol ester derivatives in food and biological model systems. Food Chem. 2018;261:267–273.
  • Athar M, Back J, Tang X, et al. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol. 2007;224(3):274–283.
  • Banu SK, Stanley JA, Sivakumar KK, et al. Resveratrol protects the ovary against chromium-toxicity by enhancing endogenous antioxidant enzymes and inhibiting metabolic clearance of estradiol. Toxicol Appl Pharmacol. 2016;303:65–78.
  • Said RS, El-Demerdash E, Nada AS, et al. Resveratrol inhibits inflammatory signaling implicated in ionizing radiation-induced premature ovarian failure through antagonistic crosstalk between silencing information regulator 1 (SIRT1) and poly(ADP-ribose) polymerase 1 (PARP-1). Biochem Pharmacol. 2016;103:140–150.
  • Chen ZG, Luo LL, Xu JJ, et al. Effects of plant polyphenols on ovarian follicular reserve in aging rats. Biochem Cell Biol. 2010;88(4):737–745.
  • Liu M, Yin Y, Ye X, et al. Resveratrol protects against age-associated infertility in mice. Hum Reprod. 2013;28(3):707–717.
  • Wang X, He Y, Liu M, et al. Lentivirus-mediated bcl-2 gene therapy improves function and structure of chemotherapy-damaged ovaries in wistar rats. Am J Reprod Immunol. 2013;69(5):518–528.
  • Kong XX, Fu YC, Xu JJ, et al. Resveratrol, an effective regulator of ovarian development and oocyte apoptosis. J Endocrinol Invest. 2011;34(11):e374–e381.
  • Luo LL, Huang J, Fu YC, et al. Effects of tea polyphenols on ovarian development in rats. J Endocrinol Invest. 2008;31(12):1110–1118.
  • Nguyen Q, Zerafa N, Liew S, et al. Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes. Mol Hum Reprod. 2019;25(8):433–444.
  • Nelson S. Biomarkers of ovarian response: current and future applications. Fertil Steril. 2013;99(4):963–969.
  • Visser J, de Jong F, Laven J, et al. Anti-Müllerian hormone: a new marker for ovarian function. Reproduction. 2006;131(1):1–9.
  • Seifer DB, Merhi Z. Is AMH a regulator of follicular atresia? J Assist Reprod Genet. 2014;31(11):1403–1407.
  • Chen XY, He-Xia X, Hai-Yun G, et al. Follicle loss and apoptosis in cyclophosphamide-treated mice: what’s the matter? Int J Mol Sci. 2016;17(6):836–842.
  • Howitz KT, Bitterman KJ, Cohen HY, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425(6954):191–196.
  • Smith JJ, Gagne DJ,JL, Boss O, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature. 2007;450(7170):712–716.
  • Zhou X, Ni Y, Luo L. Biological characteristics of SIRT1 and its effect on ovarian follicle development. Chin J Clin. 2015;22:4166–4171.
  • Liu L, Rajareddy S, Reddy P, et al. Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a. Development. 2007;134(1):199–209.
  • Pelosi E, Omari S, Michel M, et al. Constitutively active Foxo3 in oocytes preserves ovarian reserve in mice. Nat Commun. 2013;4:1843.
  • Solomon JM, Pasupuleti R, Xu L, et al. Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol. 2006;26(1):28–38.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.